PETER JINDRA to Graft vs Host Disease
This is a "connection" page, showing publications PETER JINDRA has written about Graft vs Host Disease.
Connection Strength
0.346
-
Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT. Bone Marrow Transplant. 2024 02; 59(2):224-231.
Score: 0.148
-
Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT. Bone Marrow Transplant. 2021 03; 56(3):614-621.
Score: 0.119
-
Association of IL6 and CCL2 gene polymorphisms with the outcome of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2009 Aug; 44(4):227-35.
Score: 0.053
-
Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2014 Mar; 49(3):389-96.
Score: 0.019
-
Allogeneic BMT in patients above 45 years of age: a single center experience. Bone Marrow Transplant. 2001 Apr; 27(7):723-6.
Score: 0.008